Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Harrington-Smith Kristen Create: Alert

All | News | Filings
Date FiledTypeDescription
01/24/2023 4 Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 28,125 options to buy @ $0.4688, valued at $13.2k
11/18/2022 4 Harrington-Smith Kristen (SVP & CHIEF COMMERCIAL OFFICER) has filed a Form 4 on ImmunoGen, Inc.
Txns: Exercised 25,000 restricted stock units @ $0
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $4.61, valued at $184.4k
02/17/2022 3 Harrington-Smith Kristen (Director) has filed a Form 3 on eFFECTOR Therapeutics, Inc.
11/17/2021 4 Harrington-Smith Kristen (SVP & Chief Commercial Officer) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 75,000 restricted stock units @ $0
Granted 450,000 options to buy @ $5.68, valued at $2.6M
11/17/2021 3 Harrington-Smith Kristen (SVP & Chief Commercial Officer) has filed a Form 3 on ImmunoGen, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy